Search Results

Disclsoure Ref 2025143 - Expenditure over the last financial year 24 & 25 of Medical Locum Doctors via off-framework suppliers.pdf

Appendix 7 - COVID-19 TO SWAB OR NOT TO SWAB.docx

DCHS Declaraton - Staff Admin & Managers.pdf

Confidentiality Code of Conduct.docx

All employees are bound by a legal duty of confidence to protect personal information they may come into contact with during the course of their work.

A7 - Patient Enquiries to Respiratory Administration (S88).docx

8 Steps to Patient Isolation (L343)

Disclosure Ref 2024257 - RPA and automation.pdf

Freedom of Information request relating to RPA used within the Trust

Blood Transfusion Policy (P25)

This Policy and associated pathway have been developed and reviewed to ensure the safe practice relating to the transfusion of blood and blood components. The Policy is based on recommendations laid down by the British Task Force under the auspices of the British Standards for Haematology and other published guidelines, including the NPSA Notice ‘Right Blood, Right Patient’ November 2006.

Staff Forum Agenda October 2021.pdf

The Management of Warfarin Therapy for Inpatients Guidelines (G233)

The aim of this guideline is to improve the safety of anticoagulant therapy for inpatients under the care of DCHS by: • Providing an evidence-based algorithm for the initiation of warfarin therapy in atrial fibrillation, including the use of a specific SystmOne template for warfarin management. • Offering an evidence-based algorithm to guide maintenance dosing decisions. • Clarifying the process for communicating follow-up arrangements to primary care teams when a patient is discharged from hospital. • Endorsing the level of competence and training required of clinicians who prescribe warfarin. • Ensuring that the guidance will be built into an audit and review cycle.